Acebutolol detailed information: Difference between revisions
No edit summary |
|||
Line 27: | Line 27: | ||
'''| [[Acebutolol clinical pharmacology|Clinical Pharmacology]]''' | '''| [[Acebutolol clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[Acebutolol nonclinical toxicology|Nonclinical Toxicology]]''' | '''| [[Acebutolol nonclinical toxicology|Nonclinical Toxicology]]''' | ||
'''| [[Acebutolol how supplied storage and handling|How Supplied/Storage and Handling]]''' | '''| [[Acebutolol how supplied storage and handling|How Supplied/Storage and Handling]]''' | ||
'''| [[Acebutolol patient counseling information|Patient Counseling Information]]''' | '''| [[Acebutolol patient counseling information|Patient Counseling Information]]''' |
Revision as of 20:32, 3 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
For patient information about Acebutolol, click here
Synonyms / Brand Names: SECTRAL®
Overview
Sectral (acebutolol HCl) is a selective, hydrophilic beta-adrenoreceptor blocking agent with mild intrinsic sympathomimetic activity for use in treating patients with hypertension and ventricular arrhythmias
Category
Cardiovascular Drugs:Beta blockers
FDA Package Insert
| Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages